Johanna Marlies Schafer, Ph.D.
Jennifer Pietenpol lab
Identification and characterization of MYCN-expressing triple-negative breast cancer: Implications for therapeutic strategies
Recent Papers:Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors Science Translational Medicine PMID: 32161105
How Vanderbilt made an impact: Core facilities at Vanderbilt, such as the High-Throughput Screening (HTS) facility, Translational Pathology Shared Resource (TPSR), and Digital Histology Shared Resource (DHSR), provided valuable resources that enabled high-impact research. The Biochemistry Department and the ASPIRE program out of the Biomedical Research Education and Training (BRET) office were vital to my education and career development.
Next plans: Postdoctoral studies